218 related articles for article (PubMed ID: 24276237)
1. MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERα)-positive mammary adenocarcinomas.
Mukherjee M; Ge G; Zhang N; Edwards DG; Sumazin P; Sharan SK; Rao PH; Medina D; Pati D
Oncogene; 2014 Nov; 33(48):5511-5522. PubMed ID: 24276237
[TBL] [Abstract][Full Text] [Related]
2. Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice.
Mukherjee M; Ge G; Zhang N; Huang E; Nakamura LV; Minor M; Fofanov V; Rao PH; Herron A; Pati D
PLoS One; 2011; 6(7):e22167. PubMed ID: 21799785
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Separase induces aneuploidy and mammary tumorigenesis.
Zhang N; Ge G; Meyer R; Sethi S; Basu D; Pradhan S; Zhao YJ; Li XN; Cai WW; El-Naggar AK; Baladandayuthapani V; Kittrell FS; Rao PH; Medina D; Pati D
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13033-8. PubMed ID: 18728194
[TBL] [Abstract][Full Text] [Related]
4. Hormone-induced chromosomal instability in p53-null mammary epithelium.
Pati D; Haddad BR; Haegele A; Thompson H; Kittrell FS; Shepard A; Montagna C; Zhang N; Ge G; Otta SK; McCarthy M; Ullrich RL; Medina D
Cancer Res; 2004 Aug; 64(16):5608-16. PubMed ID: 15313898
[TBL] [Abstract][Full Text] [Related]
5. Biology and insights into the role of cohesin protease separase in human malignancies.
Zhang N; Pati D
Biol Rev Camb Philos Soc; 2017 Nov; 92(4):2070-2083. PubMed ID: 28177203
[TBL] [Abstract][Full Text] [Related]
6. Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma.
Tilli MT; Frech MS; Steed ME; Hruska KS; Johnson MD; Flaws JA; Furth PA
Am J Pathol; 2003 Nov; 163(5):1713-9. PubMed ID: 14578170
[TBL] [Abstract][Full Text] [Related]
7. ESPL1 is a candidate oncogene of luminal B breast cancers.
Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
[TBL] [Abstract][Full Text] [Related]
8. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
9. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.
Davis VL; Shaikh F; Gallagher KM; Villegas M; Rea SL; Cline JM; Hughes CL
Horm Cancer; 2012 Dec; 3(5-6):227-39. PubMed ID: 22968785
[TBL] [Abstract][Full Text] [Related]
11. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.
Wang X; Zhou YX; Qiao W; Tominaga Y; Ouchi M; Ouchi T; Deng CX
Oncogene; 2006 Nov; 25(54):7148-58. PubMed ID: 16715125
[TBL] [Abstract][Full Text] [Related]
13. Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.
Hodgson MC; Vanostran G; Alghamdi S; Poppiti RJ; Agoulnik AI; Agoulnik IU
PLoS One; 2013; 8(4):e60455. PubMed ID: 23593223
[TBL] [Abstract][Full Text] [Related]
14. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.
Campbell MJ; Wollish WS; Lobo M; Esserman LJ
In Vitro Cell Dev Biol Anim; 2002 Jun; 38(6):326-33. PubMed ID: 12513120
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY
Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107
[TBL] [Abstract][Full Text] [Related]
16. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
[TBL] [Abstract][Full Text] [Related]
17. Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer.
Milliken EL; Lozada KL; Johnson E; Landis MD; Seachrist DD; Whitten I; Sutton AL; Abdul-Karim FW; Keri RA
Oncogene; 2008 Mar; 27(12):1759-66. PubMed ID: 17891171
[TBL] [Abstract][Full Text] [Related]
18. Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.
Herynk MH; Lewis MT; Hopp TA; Medina D; Corona-Rodriguez A; Cui Y; Beyer AR; Fuqua SA
Oncogene; 2009 Sep; 28(36):3177-87. PubMed ID: 19561644
[TBL] [Abstract][Full Text] [Related]
19. Conditional expression of Ki-Ras
Andò S; Malivindi R; Catalano S; Rizza P; Barone I; Panza S; Rovito D; Emprou C; Bornert JM; Laverny G; Metzger D
Oncogene; 2017 Nov; 36(46):6420-6431. PubMed ID: 28745321
[TBL] [Abstract][Full Text] [Related]
20. Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology.
Chooi KF; Carter DA; Biswas S; Lightman SL; Ho MY; Murphy D
Cancer Res; 1994 Dec; 54(24):6434-40. PubMed ID: 7987839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
